BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38579477)

  • 1. Comment on: Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer.
    Xu R
    Oral Oncol; 2024 May; 152():106767. PubMed ID: 38579477
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer.
    Hei H; Luo Z; Zheng C; Gong W; Zhou B; Fang J; Qin J
    Oral Oncol; 2023 Nov; 146():106563. PubMed ID: 37690364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Reference to: How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
    Megwalu UC
    Laryngoscope; 2023 Mar; 133(3):E21. PubMed ID: 36271915
    [No Abstract]   [Full Text] [Related]  

  • 4. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
    Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW
    Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features of postoperative cervical lymph nodes recurrence in papillary thyroid carcinoma].
    He YY; Zhang B; Zhang YB; Xu ZG; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):416-420. PubMed ID: 28635212
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cystic cervical lymph node swelling - Thyroglobin-FNA allows to diagnose metastasizing papillary thyroid carcinoma].
    Smaxwil C; Esianu E; Altmeier J; Zielke A
    Laryngorhinootologie; 2022 Aug; 101(8):669-670. PubMed ID: 35915904
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive value of metastatic lateral lymph node ratio for recurrence in pathologically lateral lymph node-positive papillary thyroid cancer patients with palpable lymph nodes.
    Dong W; Horiuchi K; Noguchi E; Okamoto T
    Head Neck; 2022 Jul; 44(7):1623-1630. PubMed ID: 35452140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
    Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
    Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing a prediction model for lateral neck lymph node metastasis in patients with papillary thyroid carcinoma.
    Jin S; Bao W; Yang YT; Bai T; Bai Y
    Sci Rep; 2018 Nov; 8(1):17355. PubMed ID: 30478394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of Delphian lymph node metastasis in papillary thyroid carcinoma.
    He Q; Zhu Q; Dong J; Wu Y
    Asian J Surg; 2020 Dec; 43(12):1180-1181. PubMed ID: 32988704
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the role of prophylactic bilateral central neck lymph node dissection in patients with papillary thyroid carcinoma: a case controlled study.
    Shahriarirad R; Meshkati Yazd SM; Zahedi R; Mokhtari Ardekani A; Rekabi MM; Nasiri S
    Updates Surg; 2023 Apr; 75(3):679-689. PubMed ID: 36527603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
    Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
    Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level.
    Jeon MJ; Kim WG; Jang EK; Choi YM; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
    Thyroid; 2015 Apr; 25(4):410-6. PubMed ID: 25607926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to "lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid".
    Akhtar A; Akhtar R; Zaidi E
    Oral Oncol; 2024 Mar; 150():106718. PubMed ID: 38350260
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma.
    Zhao H; Wang Y; Wang MJ; Zhang ZH; Wang HR; Zhang B; Guo HQ
    BMC Cancer; 2017 Apr; 17(1):296. PubMed ID: 28454525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parapharyngeal Lymph Node Metastasis From Papillary Thyroid Carcinoma.
    Masmoudi M; Hasnaoui M; Njima M; Zitouni C; Thabet W; Chebil E; Mighri K
    Ear Nose Throat J; 2024 Mar; 103(3):NP164-NP167. PubMed ID: 34558348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma.
    Lang BH; Tang AH; Wong KP; Shek TW; Wan KY; Lo CY
    Ann Surg Oncol; 2012 Oct; 19(11):3472-8. PubMed ID: 22565664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy.
    Xing Z; Qiu Y; Li Z; Zhang L; Fei Y; Zhu J; Su A
    BMC Surg; 2021 Jan; 21(1):53. PubMed ID: 33482804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel Lymph Node Biopsy Status Correlates with Postoperative Stimulated Thyroglobulin Levels in Low-risk Papillary Thyroid Cancer Patients.
    Saliba J; Payne RJ; Varshney R; Sela E; Maniakas A; Rahme E; Mlynarek A; Caglar D; Hier MP; Tamilia M
    Endocr Pract; 2014 May; 20(5):399-404. PubMed ID: 24325994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.